Mailing Address:
Harvard Medical School
Department of Population Medicine
133 Brookline Avenue, 6th Floor
Boston, MA 02215
Jeff_Brown@harvardpilgrim.org
Phone: (617) 509-9986
Fax: (617) 859-9853
Staff Assistant: Sophie Jewkes
|
Jeff Brown, PhD
Dr. Brown is an Assistant Professor in the Department of Population Medicine and a health services researcher with expertise in health policy, health economics, pharmacoepidemiology, and outcomes research. His interests include evaluating the clinical, safety, and economic consequences of the adoption and diffusion of new medical technologies. Other research interest included patient-preferences and cost-effectiveness studies. He is responsible for oversight of the research data resources of HMO Research Network (http://www.hmoresearchnetwork.org) Center for Education and Research in Therapeutics (CERT) (http://www.certs.hhs.gov/). His current research is primarily focused on multisite pharmacoepidemiology research using large administrative data systems.
Selected Publications:
Brown JS,Kulldorff M,Petronis KR,Reynolds R,Chan KA,Davis RL,Graham D,Andrade SE,Raebel MA,Herrinton L,Roblin D,Boudreau D,Smith D,Gurwitz JH,Gunter MJ,Platt R,.
Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations
.
Pharmacoepidemiol Drug Saf. 2009 Mar;3:226-234
Moore KM,Duddy A,Braun MM,Platt R,Brown JS,.
Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans
.
Pharmacoepidemiol Drug Saf. 2008 Dec;12:1137-1141
Velentgas P,Bohn RL,Brown JS,Chan KA,Gladowski P,Holick CN,Kramer JM,Nakasato C,Spettell CM,Walker AM,Zhang F,Platt R,.
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study23
.
Pharmacoepidemiol Drug Saf. 2008 Dec;12:1226-1234
Andrade SE,Raebel MA,Brown J,Lane K,Livingston J,Boudreau D,Rolnick SJ,Roblin D,Smith DH,Dal Pan GJ,Scott PE,Platt R,.
Outpatient use of cardiovascular drugs during pregnancy56
.
Pharmacoepidemiol Drug Saf. 2008 Mar;3:240-247
Andrade SE,Raebel MA,Brown J,Lane K,Livingston J,Boudreau D,Rolnick SJ,Roblin D,Smith DH,Willy ME,Staffa JA,Platt R,.
Use of antidepressant medications during pregnancy: a multisite study72
.
Am J Obstet Gynecol. 2008 Feb;2:194-195
Holmes JH,Brown J,Hennessy S,Lane K,Langer RD,Lazarus R,O'Connor PJ,Strom BL,Platt R,.
Developing a distributed research network to conduct population-based studies and safety surveillance
.
AMIA Annu Symp Proc. 2008;973-
Brown JS,Kulldorff M,Chan KA,Davis RL,Graham D,Pettus PT,Andrade SE,Raebel MA,Herrinton L,Roblin D,Boudreau D,Smith D,Gurwitz JH,Gunter MJ,Platt R,.
Early detection of adverse drug events within population-based health networks: application of sequential testing methods
.
Pharmacoepidemiol Drug Saf. 2007 Dec;12:1275-1284
Lieu TA,Kulldorff M,Davis RL,Lewis EM,Weintraub E,Yih K,Yin R,Brown JS,Platt R,.
Real-time vaccine safety surveillance for the early detection of adverse events
.
Med Care. 2007 Oct;10 Supl 2:S89-S95
Simoni-Wastila L,Ross-Degnan D,Mah C,Gao X,Brown J,Cosler LE,Fanning T,Gallagher P,Salzman C,Soumerai SB,.
A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders
.
Clin Ther. 2004 Feb;2:322-336
Ross-Degnan D,Simoni-Wastila L,Brown JS,Gao X,Mah C,Cosler LE,Fanning T,Gallagher P,Salzman C,Shader RI,Inui TS,Soumerai SB,.
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population
.
Int J Psychiatry Med. 2004;2:103-123
|
